Akoya Biosciences has opened its Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts to meet the accelerating demand for its spatial biology solutions and the increased utilization of the company’s PhenoCycler-Fusion and the PhenoImager HT platforms. “Spatial biology is transforming drug discovery, translational sciences, and clinical research, and advancing our ability to understand biology, disease progression, and patients’ response to therapy,” said Brian McKelligon, CEO of Akoya Biosciences. “The vast potential of spatial biology, combined with the higher throughput and plex capabilities of our systems, are driving increased demand for our reagents. We expect our investment in the Manufacturing Center of Excellence will drive operational efficiencies, allowing us to better serve our customers, deliver reagents at increasing scale, and further broaden our portfolio of reagents to unlock new market opportunities.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKYA:
- Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
- Akoya, Shanghai KR announce KR-HT5 receive premarket approval from China’s NMPA
- Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
- Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
- Akoya Biosciences showcases spatial biology 2.0 solutions at AACR meeting